Sanofi
Latest statistics and disclosures from Sanofi's latest quarterly 13F-HR filing:
- Top 5 stock holdings are MGTX, NVAX, INBX, ANAB, IMRX, and represent 93.40% of Sanofi's stock portfolio.
- Added to shares of these 1 stock: IMRX (+$19M).
- Started 1 new stock position in IMRX.
- Reduced shares in these 2 stocks: INZY, IGMS.
- Sold out of its positions in IGMS, INZY.
- Sanofi was a net buyer of stock by $16M.
- Sanofi has $260M in assets under management (AUM), dropping by 48.15%.
- Central Index Key (CIK): 0001121404
Tip: Access up to 7 years of quarterly data
Positions held by Sanofi consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Sanofi
Sanofi holds 9 positions in its portfolio as reported in the September 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Meiragtx Holdings (MGTX) | 38.6 | $100M | 12M | 8.23 |
|
|
| Novavax Com New (NVAX) | 22.9 | $60M | 6.9M | 8.67 |
|
|
| Inhibrx Biosciences (INBX) | 15.0 | $39M | 1.2M | 33.68 |
|
|
| Anaptysbio Inc Common (ANAB) | 9.7 | $25M | 822k | 30.62 |
|
|
| Immuneering Corp Class A Com (IMRX) | 7.3 | $19M | NEW | 2.7M | 7.00 |
|
| Omada Health (OMDA) | 4.5 | $12M | 525k | 22.11 |
|
|
| LAVA Therapeutics SHS (LVTX) | 1.2 | $3.0M | 1.9M | 1.56 |
|
|
| Eledon Pharmaceuticals (ELDN) | 0.8 | $2.1M | 815k | 2.59 |
|
|
| Q32 Bio (QTTB) | 0.2 | $483k | 244k | 1.98 |
|
Past Filings by Sanofi
SEC 13F filings are viewable for Sanofi going back to 2025
- Sanofi 2025 Q3 filed Nov. 4, 2025
- Sanofi 2025 Q2 filed July 29, 2025